- Potentially Treatable Condition
- Cancer
- HOME
- ABOUT
- RESEARCH
- INSIGHTS & HAPPENINGS
- JOIN US
- CONTACT US
-
Menu
Cancer is a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body. Cancer can start almost anywhere in the human body.
Normally, human cells grow and multiply (through a process called cell division) to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place.
Sometimes this orderly process breaks down, and abnormal or damaged cells grow and multiply when they shouldn’t. These cells may form tumors, which are lumps of tissue. Tumors can be cancerous or not cancerous (benign).
Signs and symptoms caused by cancer will vary depending on the affected body part. Some general signs and symptoms associated with cancer, but not specific to it, includes:
There is no cure for cancer, and the most common conventional therapies are highly invasive and unnatural procedures, including chemotherapy, radiation therapy, surgery, hormonal therapy and immunotherapy.
By removing the infected part through surgical removal, it may lead to dysfunction in certain parts of the body.
Other conventional therapies only attempt to lower the patient’s pain levels without addressing the causes of the pain. Radiation therapy can also have negative effects on surrounding cells, even when targeted specifically at a tumor or cancer. Conventional physicians may also provide powerful pain medication to cancer patients, which can cause complications if used for too long. These medications can only be prescribed for short periods, after which the patient returns to the same painful and degenerative experience without any meaningful improvement to their underlying condition. Clearly, a new approach to cancer treatment is needed.
CelltiNK is a type of cytotoxic lymphocyte critical to the innate immune system. The role CelltiNK plays is analogous to that of cytotoxic T cells in the human adaptive immune response.
CelltiNK provides rapid responses to virus-infected cells, acting within days after being administered and responding to tumour formations. Typically, immune cells detect major histocompatibility complex (MHC) present on infected cell surfaces, triggering a cytokine release, and causing tumour lysis or apoptosis. CelltiNK can apply to replace the insufficient Natural Killer cells (NK cells) in cancer patient body Natural killer (NK) cells are effector lymphocytes of the innate immune system that control several types of tumors and microbial infections by limiting their spread and subsequent tissue damage.
CelltiNK is cytotoxic against a wide range of tumor cells of solid cancer types
While we tailor each treatment to the unique needs of each patient, we will walk most patients through the following 3 steps.
If you believe that our treatment options may be able to improve your condition and enhance your quality of life, please contact us to schedule a complimentary consultation with one of our in-house clinical specialists. Our consultations are available in both Malay and English language.
Founded in 2010, Cell Tissue Group is a pioneering Malaysian medical technology company and a spin-off from the National University of Malaysia (UKM). As Malaysia’s first Tissue Engineering firm, Cell Tissue Group operates within a certified cGMP laboratory, ensuring the highest standards of medical research and product development, particularly in Tissue Engineering and Regenerative Medicine.
Founded in 2010, Cell Tissue Group is a pioneering Malaysian medical technology company and a spin-off from the National University of Malaysia (UKM). As Malaysia’s first Tissue Engineering firm, Cell Tissue Group operates within a certified cGMP laboratory, ensuring the highest standards of medical research and product development, particularly in Tissue Engineering and Regenerative Medicine.
Proudly powered by CTG © 2010-2024 Cell Tissue Group, a Universiti Kebangsaan Malaysia Spin-Off Company. – All Rights Reserved.